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ROLE OF NITRIC OXIDE IN 
HUMAN ESOPHAGEAL 
CIRCULAR SMOOTH 
MUSCLE IN VITRO 
The role of nitric oxide in human esophageal smooth muscle was examined. 
Immunostaining for constitutive nitric oxide synthase labeled nerve fibers 
and bundles within longitudinal and circular smooth muscle layers of 
resected tissue samples. Strips of circular muscle mounted in organ baths 
exhibited spontaneous contractions and active tone. When exposed to 
5-second trains of electric field stimulation at 20 Hz, most strips exhibited 
intrastimulus "on" and poststimulus "off" contractions. Exposure to a 0.1 
/xmol/L (or greater) concentration of atropine converted "on" contractions 
to "on" relaxations and reduced "off" contractions by 63%. Exposure to 
NG-nitro-L-arginine resulted in concentration-dependent enhancement of 
"on" contractions and abolition of "off" contractions. Excess L-arginine 
enhanced the reversal of these effects. Sodium nitroprusside inhibited both 
spontaneous and evoked contractions. These results suggest that nitric 
oxide synthesis is a mediator of neural inhibition of human esophageal 
circular smooth muscle and is necessary for the occurrence of "off" 
contractions. (J THORAC CARDIOVASC SURG 1995;110:157-64) 
William G. Richards, PhD," Jonathan S. Stamler, MD, b Lester Kobzik, MD, c 
and David J. Sugarbaker , MD, a Boston, Mass., and Durham, N.C. 
p eristalsis in the distal segment of the human 
esophagus is poorly understood. Experiments 
with animals in vivo have revealed that esophageal 
peristalsis involves coordinated contraction of the 
inner muscularis mucosa and the outer longitudinal 
and  circular layers of  smooth muscle. 1Contractions 
that resemble peristalsis urvive bilateral vagotomy z 
and occur in vitro, 3 suggesting that mechanisms 
capable of controlling sequential contraction exist 
within the intramural nerve plexuses. In the opos- 
sum, the circular muscle is initially hyperpolarized 
during stimulation or swallow induction and subse- 
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quently depolarizes, fires action potentials, and con- 
tracts as the peristaltic wave passes the recorded 
region.l, e Electric field stimulation (EFS) in vitro 
produces intrastimulus "on"  and poststimulus "off" 
contractions in strips of animal 4-6 and human 7 cir- 
cular muscle. The "on" response is likely to repre- 
sent EFS-produced activation of cholinergic nerves, 
as it is abolished by atropine. 6 The "off" contraction 
is apparently related to EFS-produced nonadrener- 
gic, noncholinergic neural inhibition and may rep- 
resent a "rebound" effect. 8
Nitric oxide has been proposed as a mediator of 
nonadrenergic, noncholinergic inhibition of esoph- 
ageal smooth muscle based on the results of animal 
studies. 9-12 In this study, localization of constitutive 
nitric oxide synthase (c-NOS) within the human 
esophageal muscularis externa was accomplished by 
immunostaining, and the role of  nitric oxide synthe- 
sis in the in vitro field-stimulated responses of 
human circular muscle was investigated with the use 
of the competitive inhibitor NG-nitro-L-arginine (L- 
NNA).  Preliminary reports of some of these exper- 
iments have been published. 13' 14 
Materials and methods 
Tissue procurement. Samples of smooth muscle were 
obtained from uninvolved regions (7 to 11 cm above the 
lower esophageal sphincter) of surgical specimens (n = 7) 
resected for esophageal cancer. A protocol for experimen- 
tal use of :human discarded material was approved by the 
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Committee for the Protection of Human Subjects from 
Research Risk at Brigham and Women's Hospital. Sam- 
ples were placed in Dulbecco's modified Eagle's medium 
gassed with 95% oxygen and 5% carbon dioxide on ice 
within minutes of resection. 
Immunohistoehemistry. The presence of c-NOS in this 
tissue was determined by immunostaining. Cryostat sec- 
tions (8 /xm) obtained from O.C.T. (Tissue-Tek, Miles, 
Inc., Elkhart, Ind.) embedded slices of esophageal tissue 
consisting of both longitudinal and circular muscle were 
exposed to a polyclonal rabbit antibody preparation that 
was generated by immunization with rat brain c-NOS and 
that had undergone affinity purification on c-NOS anti- 
gen. 15 The sections were first incubated overnight with 
primary specific c-NOS antibody or, in the case of con- 
trols, with dilutions of commercially prepared rabbit 
immun0globulin G. A biotin-conjugated goat antirabbit 
immunoglobulin G, avidin-biotin peroxidase complex 
(Vector Labs, Burlingame, Calif.) and a substrate solution 
were used to detect specific binding. The substrate solu- 
tion consisted of 0.03% hydrogen peroxide and a 2 mg/ml 
concentration of diaminobenzidine in Tris-saline solution 
(0.5 mol/L) with imidazole (1 mol/L) and 0.3% azide (to 
block endogenous peroxidase) at pH 7.7. Sections were 
counterstained lightly with hematoxalin, dehydrated, and 
covered with a coverslip. 
Organ bath experiments. Each sample was pinned with 
the mucosal surface up in a Sylgard-bottom Petri dish 
(Dow Corning Corp., Midland, Mich.) and immersed in 
cold, gassed Dulbecco's medium. The mucosa was re- 
moved by sharp dissection. Strips of circular muscle were 
cut parallel to the fibers and dissected free from the 
longitudinal muscle layer with a dissecting microscope. 
Each strip was approximately 1 cm by 3 mm and contained 
only circular fibers. 
The strips were suspended in water-jacketed organ 
baths, which accommodated two strips each. One end of 
each strip was anchored, and the other end was attached 
with stainless teel hooks to a force transducer (World 
Precision Instruments, Sarasota, Fla., FORT-10) for iso- 
metric tension recording. Tension signals from the force 
transducers were amplified (World Precision, TBM-4) 
and digitized (Axon Instruments, Foster City, Calif., TL-1, 
Axotape) at 10 Hz on-line. Each strip was positioned 
between two platinum stimulating electrodes (5 mm 
apart). Strips were immersed in 50 ml continuously gassed 
Krebs buffer (composition, in miUimoles per liter: Na +, 
138.6; K +, 5.9; Ca ++, 2.5; Mg ++, 1.2; C1 , 134; HCO3-, 
15.5; H2PO 4 , 1.2; glucose, 11.5; pH7.4 _+ 0.05) at 37 ~ _+ 
0.5 ~ C. All bathing solutions used during the experiments 
consisted of freshly prepared, prewarmed, pregassed 
buffer with or without additional dissolved substances. All 
reagents were obtained from Sigma Chemical Company 
(St. Louis, Mo.) unless otherwise stated. After 5 minutes 
the strips were gradually stretched to 130% of their 
original ength. This degree of stretch was determined in 
pilot studies (two specimens) to result in optimal re- 
sponses to EFS. All strips were allowed to equilibrate 1 
hour before stimulation. 
EFS was administered via the platinum electrodes that 
were connected to an isolated stimulator (Grass Instru- 
metat Co., Quincy, Mass., SIU5, $11) programmed to 
deliver trains of square pulses with parameters (120 V; 
20 Hz; 1 msec pulse duration; 5-second train duration) 
producing optimal responses in this tissue, based on pilot 
studies in two specimens and in agreement with published 
data. 7EFS was administered to each strip twice or four 
times per series at 2-minute intervals, and responses were 
averaged over the series. Series of EFS were repeated 
until responses to EFS exhibited stable amplitudes. The 
response to the final EFS series in buffer alone was 
considered the control response. Subsequent "off" re- 
sponses, recorded during incubation in L-NNA, were 
expressed as a percentage of control. Because control 
"on" responses often had zero or negative amplitudes, 
"on" contractions in L-NNA were expressed as a percent- 
age of the maximum (asymptotic) "on" response re- 
corded. 
So that the effects of nitric oxide synthesis on EFS- 
produced responses could be determined, solutions of 
Krebs buffer containing L-NNA were added to each bath 
in 50 /xl volumes to produce a series of cumulatively 
increasing concentrations (10 nmol/L to 300/xmol/L), and 
EFS (20 Hz) was administered after 5 minutes' incubation 
at each concentration. After exposure to L-NNA, each 
Organ bath was rinsed twice with 50 ml fresh buffer. To 
determine whether excess L-arginine would lead to recov- 
ery of "off" responses after I.-NNA exposure, we arbi- 
trarily divided the strips into two groups. L-arginine (10 
/xmol/L final concentration) was then added to the organ 
baths of one group, whereas the other group remained in 
Krebs buffer and served as controls. Series of EFS were 
applied at 10-minute intervals to all strips. In a separate 
group of strips (n = 8), sodium nitroprusside was added in 
50 /xl of buffer (final concentration 1 to 30 /xmol/L) to 
assess the responses of strips to exogenous nitric oxide. 
Statistics. Computer-assisted analysis of tension re- 
cordings was accomplished with custom software. Digi- 
tized waveforms were plotted, allowing on-screen mea- 
surement of various parameters (e.g., average tone, 
response amplitude, latency) with adjustable cursors. Me- 
dian effective concentrations (ECso s) were calculated for 
L-NNA by linear substitution after regression of the steep; 
approximately linear portion (3 to 30/zmol/L concentra- 
tion of L-NNA) of the concentration/response plots 
(which encompassed the 50% point in each case). Statis- 
tical treatment involved repeated-measures analysis of 
variance and matched-pairs or two-group t tests using a 
commercial software package (BMDP Statistical Soft- 
ware, Inc., Los Angeles, Calif.). Values are expressed as 
mean _+ standard error. For analyses of variance, F ratios 
associated with main effects and interactions are reporte d 
with parenthetical (between, within) degrees of freedom 
and tail probabilities. 
Results 
Immunostaining for c-NOS resulted in dense la- 
beling of nerve bundles in the connective tissue 
between circular and longitudinal muscle layers and 
of nerve fibers among the smooth muscle fibers of 
both layers (Fig. 1,A). No structures were labeled by 
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Fig. 1. A, Immunoperoxidase staining of human esophageal smooth muscle demonstrating selectiye 
labeling of c-NOS in nerve bundles and fibers within the circular (CM) and longitudinal (LM) layers. B, 
These structures were not labeled by control antibody. Calibration: 50/xm. 
control antibody (Fig. 1, B), demonstrating the 
specificity of localization of the c-NOS antigen. 
Sixty strips from five specimens were studied in 
organ bath experiments. Wet weight of strips was 
21.7 _ 1.2 mg. Forty of the strips (67%) exhibited 
spontaneous repetitive phasic contractions (Fig. 2, 
A), which began after 66 _+ 6 minutes of equilibra- 
tion at 37~ and persisted for 134 _+ 9 minutes. 
Ongoing spontaneous activity was reversibly abol- 
ished by sodium nitroprusside (10 /xm01/L, n = 8) 
but not affected by atropine (1 /xmol/L, n = 8). 
Application of sodium nitroprusside (10 txmol/L, 
n = 8) also produced arelaxation of 0.40 _ 0.08 gm, 
indicating a level of spontaneous tone i  circular 
muscle strips. 
After 1 hour of equilibration without stimulation, 
exposure to EFS produced an intrastimulus "on" 
contraction i  42 of 60 strips, an "on" relaxation in 
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Fig. 2. Isometric tension recordings from a single human circular smooth muscle strip illustrating the 
effects of L-NNA and L-arginine on the response to electric field stimulation. Each panel depicts the 
response to a single train, the onset and offset of which are indicated by vertical ticks. A, Control responses 
exhibited by this strip in Krebs buffer consisted of a relaxation, followed by a poststimulus "off" contraction. 
Spontaneous phasic contractions are visible before the onset of stimulation. B to D, Exposure to increasing 
concentrations of L-NNA resulted in the disappearance of the "on" relaxation, the emergence and 
concentration-dependent enhancement of a stimulation-induced "on" contraction, and a concentration- 
dependent diminution of the "off" contraction. E, Sixty minutes' incubation in L-arginine after washout of 
L-NNA resulted in decrement of the "on" contraction and recovei3z of the "off" contraction. Calibration: 
1 gm• 5 seconds. 
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Fig. 3. Average intrastimulus "on" contractions exhibited by human circular smooth muscle strips in 
response to EFS during and after exposure to cumulatively increasing concentrations of L-NNA. Area 
under the response waveform is plotted as a percentage of the largest response. Error bars are _+ 1 standard 
error. A, Exposure to L-NNA resulted in concentration-dependent enhancement of "on" contractions. B,
Time-dependent diminution of enhanced "on" contractions after washout of L-NNA was significantly 
enhanced in the group of strips incubated in L-arginine (solid line) as compared with the Krebs control 
group (dashed line). 
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Fig. 4. Average poststimulus "off" contractions exhibited by human circular smooth muscle strips in 
response to EFS during and after exposure to cumulatively increasing concentrations of L-NNA. Peak "off" 
contraction amplitude isplotted as a percentage ofthe pre-L-NNA control amplitude. Error bars are + 1 
standard error. A, Exposure to L-NNA resulted in concentration-dependent iminution and eventual 
abolition of "off" contractions. B, Strips exposed to L-arginine (solid line) exhibited a time-dependent 
recovery of almost 90% of pre-L-NNA control response amplitude, whereas control strips not exposed to 
L-arginine (dashed line) exhibited only minimal recovery of "off" responses. 
6 of 60 strips (Fig. 2, A), and/or a poststimulus "off" 
contraction in 57 of 60 strips (Fig. 2, A). "On" 
contractions were often multiphasic and thus were 
quantified in terms of the area under the response 
waveform. Addition of atropine (0.1/xmol/L, n = 8) 
abofished "on" contractions and resulted in the 
appearance of intrastimulus relaxation responses. 
"Off"  contractions were typically monophasic and 
were quantitated in terms of peak amplitude: Con- 
trol "off" response amplitudes were significantly 
larger (t[58] = 5.05; p < 0.0001) in  strips that 
exhibited spontaneous phasic contractions (5.55 + 
0.56 gm) than in those that did not (1.28 + 0.42 gm). 
Atropine (1 ~mol/L, n = 8) reduced "off" response 
amplitudes by 63% _+ 3%. Both "on" and "off" 
responses to EFS were reversibly eliminated by 
application of sodium nitroprusside (10 /xmol/L) 
and permanently abolished by tetrodotoxin (1/xmol/ 
L). 
Cumulative addition of L-NNA (n = 14) resulted 
in a concentration-dependent (F[9,117] = 53.2; p < 
0.0001; ECso = 7.9 t~mol/L) enhancement of "on" 
contractions (Figl 2, B to D, and Fig. 3, A), which 
generally became monophasic in higher concentra- 
tions of L-NNA. The L-NNA-enhanced "on" con- 
traction was reduced in amplitude by 92% ___ 3% 
after the addition of atropine (final concentration 1 
/xmol/L) and then abolished after the further addi- 
tion of hexamethonium (final concentration 10 
txmol/L). Repeated-measures analysis of variance 
revealed a time-dependent reversal of these effects 
of L-NNA (F[6,72] = 105;p < 0.0001) after washout 
of the antagonist. This reversal was significantly 
augmented by the presence of excess L-arginine 
(Figs. 2, E, and 3, B), as revealed by a significant 
main effect of L-arginine xposure (F[1,12] = 13.79; 
p < 0.005) and a significant interaction between 
L-arginine exposure and time variables (F[6,72] = 
34.07; p < 0.0001). 
Addition of L-NNA also resulted in a concentra- 
tion-dependent (F[9,126] = 33.7; p < 0.0001; ECs0 = 
6.3 ~mol/L) diminution and eventual abolition of 
"off" contractions (Fig. 2, B to D, and Fig. 4, A). 
Time-dependent recovery of "off" contraction am- 
plitude (F[6,72] = 22.9; p < 0.0001) was enhanced 
by addition of L-arginine (Figs. 2, E, and 4, B), as 
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indicated by a significant main effect of L-arginine 
exposure (F[1,12] = 11.43; p < 0.01) and a signifi- 
cant exposure • time interaction (F[6,72] = 9.82; 
p < 0.0001). 
Discussion 
The results of this study indicate that (1) c-NOS 
immunoreactivity is characteristic of nerves and 
nerve fibers in human esophageal smooth muscle 
and (2) inhibition of nitric oxide synthesis with 
L-NNA results in reversible and concentration-de- 
pendent alteration of contractile responses elicited 
by EFS (i.e., enhancement of "on" contractions and 
diminution of "off" contractions). 
TheSe results are consistent with a two-compo- 
nent interpretation of the response of human esoph- 
ageal circular muscle strips to EFS, and they imply a 
9 two-component euromuscular mechanism for peri- 
stalsis in the smooth muscle esophageal segment. In 
vitro, both excitatory and inhibitory components are 
activated uring a stimulus train, producing me- 
chanical relaxation, contraction, or mixed responses. 
This inconsistency is probably an artifact resulting 
from the nature of EFS, which apparently activates 
multiple intramural nerves simultaneously. Under 
most circumstances, only the excitatory component 
is evident during poststimulus responses. The inhib- 
itory component is diminished by inhibitors of nitric 
oxide synthesis, implicating nitric oxide as a media- 
tor. This interpretation is supported by finding that 
nerves and nerve fibers stain densely for c-NOS. The 
excitatory component consists of a cholinergic sub- 
component, which predominates during intrastimu- 
lus responses and accounts for at least 63% of the 
poststimulus contraction, and a noncholinergic sub- 
component, which is absent or inhibited during 
stimulation and which is manifest during the "off" 
response. 
Studies of esophageal circular muscle in several 
species have provided evidence of a nonadrenergic, 
noncholinergic nhibitory innervation of this tissue. 
Inhibitory junction potentials have been recorded 
during EFS in vitro from opossum 16 and cat 17 
circular muscle strips and during swallowing from 
exposed opossum circular muscle in vivo. 1 Evidence 
of an inhibitory response in human circular muscle 
was observed in the present study in the form of 
intrastimulus relaxation of strips not initially exhib- 
iting "on" contractions and of those exposed to 
atropine. Cholinergic "on" contractions were aug- 
mented by exposure of strips to L-NNA, suggesting 
tfiat this agent interfered with the inhibitory compo- 
nent of the response and that nitric oxide synthesis 
contributes to nonadrenergic, noncholinergic inhibi- 
tion. This thesis is supported by the observation that 
sodium nitroprusside, which releases nitric oxide 
into solution, reversibly relaxed circular muscle 
strips and abolished both spontaneou s and evoked 
contractions. Nitric oxide synthesis has also been 
found to mediate relaxation of smooth circular 
muscle of the human lower esophageal sphinc- 
ter.18, 19 
The inhibitory component of the response to EFS 
has been assumed to be related to the occurrence 
and timing of the "off" contraction. The in vitro 
"off" contraction is analogous to the peristaltic 
circular muscle contraction, in that both contrac- 
tions occur after a latent period associated with 
neurogenic nhibition. One hypothesis holds that the 
"off" contraction occurs as a result of a rebound 
effect as the smooth muscle membrane is released 
from EFS-produced inhibition and that the duration 
of the inhibitory junction potential controls the 
latency of the contraction, s Because this latency is 
regionally graded, the inhibitory component may 
have a role in controlling sequential peristaltic on- 
traction in the intact organ. 5 In the present study, 
L-NNA produced a concentration-dependent dimi- 
'nution of the "off" contraction, which indicates a 
role of nitric oxide synthesis in a critical component 
of this response. The effect of L-NNA on the "off" 
contraction mirrored its antagonism of the inhibi- 
tory component (as indicated by "on" contraction 
enhancement), a result that is not inconsistent with 
a "rebound" hypothesis. 
Esophageal manometry in human subjects has 
revealed that cholinergic manipulations profoundly 
affect peristaltic ontractions during swallowing. In- 
tramuscular 2~ or intravenous 21atropine reduced the 
incidence of swallow-associated peristalsis, as well as 
the amplitude and velocity of peristaltic ontractions 
in healthy subjects. The cholinesterase inhibitor 
edrophonium increased the amplitude and duration 
of peristaltic ontractions and decreased the peri- 
staltic velocity. 22 Correspondingly, the results of the 
present experiment revealed a conspicuous contri- 
bution of cholinergic excitation to both "on" and 
"off" responses of human esophageal circular mus- 
cle to EFSI The "on" contraction was abolished by 
atropine alone, ~ as has been reported in the opos- 
sum. 6 However, when the inhibitory component of 
the EFS response was antagonized by L-NNA, the 
enhanced "on" contraction was only 92% reduced 
by atropine. The residual contraction was abolished 
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by the further~addition f hexamethonium. The sensi- 
tivity of the "off' contraction to cholinergic antagonists 
varies significantly among species that have been ex- 
amined. In the opossum, "otF' responses are minimally 
depressed 6 or enhanced 8 by atropine, whereas they are 
completely abolished in the cat. 23 The mediator(s) of 
residual (noncholinergic) "on" and "off' contractions 
have not been identified. 
An understanding of the normal physiology of an 
organ should form the basis of a clinical approach to 
functional disorders of the organ. In the case of the 
esophagus, normal physiology has been poorly un- 
derstood, limiting clinical perspective on primary 
esophageal disorders such as achalasia, diffuse 
spasm, and nutcracker esophagus. It is now appre- 
ciated that these apparently diverse motor disorders 
may represent distinct stages along a continuum of 
intramural neuropathy. 24Specifically, these diseases 
have in common aprogressive breakdown of smooth 
muscle peristalsis and lower sphincter function pos- 
sibly attributable to degeneration of inhibitory neu- 
ronal control mechanisms. This interpretation is
supported by case reports of apparent ransition 
from nutcracker esophagus to diffuse spasm 25' 26 and 
from diffuse spasm to achalasia. 24' 27 
By identifying a mediator of smooth muscle neu- 
ronal inhibition, the present study sheds light on the 
normal physiology of esophageal peristalsis. Specif- 
ically, the results suggest hat the peristalticwave is 
dependent on the coordination of cholinergic exci- 
tation with nitric oxide-dependent inhibition. The 
ability of the inhibitory component o mask the 
contractile ffects of simultaneously present cholin- 
ergic excitation (as evidenced by the emergence of 
cholinergic "on" contractions during nitric oxide 
synthesis blockade) supports the view that a distally 
progressive release from inhibition could account 
for peristaltic propagation. This interpretation im- 
plies that neuronal excitation eed not be aborally 
sequenced, but rather that a generalized cholinergic 
tone within the segment as a whole might modulate 
the amplitude of the contraction. With progressive 
deterioration of inhibitory innervation, high-ampli- 
tude peristaltic (nutcracker) and eventually simulta- 
neous nonperista!tic (diffuse spasm) contractions 
would be expected as cholinergic excitation becomes 
tess effectively balanced and controlled by the inhib- 
itory mechanism. Manometric patterns consistent 
with diffuse esophageal spasm Can be induced ex- 
perimentally in some patients with nutcracker 
esophagus by bethanechol provocation. 2sIn achala- 
sia, severe loss of postganglionic nhibitory innerva- 
tion has been demonstrated, although cholinergic 
innervation is essentially intact. 29' 3o 
Esophageal motility disorders are generally 
treated by mitigation of esophageal smooth muscle 
function either by calcium channel blockade or by 
myotomy. Identification of the inhibitory compo- 
nent as a major contributor to normal motility and 
of nitric oxide as a neurochemical mediator may 
allow for more tailored therapy. Future studies 
aimed at developing such therapy will involve assess- 
ment of nitric oxide synthase and contractile activity 
in diseased specimens. 
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